| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 168 | 80 | 6 |
| Full Text Views | 2 | 0 | 0 |
| PDF Downloads | 0 | 0 | 0 |
Treatment of Urinary Bilharziasis in a Small Focus with Sodium Antimony Dimercaptosuccinate (Astiban®)
Summary
A slow method of administering sodium antimony dimercaptosuccinate was tried in 163 cases of haematobium bilharziasis in an effort to reduce side-effects. The drug was given over a period of 2½ weeks, the total amount being the same as tried previously in a short 5-day administration schedule.
The severity and number of side-effects were the same in both trials. However, the data suggest that the parasitologic rate of cure is reduced from 100% in the short schedule to 80% in the slow one.
Author Notes
Associate Professor, Institute of Public Health Research.
Epidemiologist, Institute of Public Health Research.
Senior Field Technician, Institute of Public Health Research.